Asia-Pacific ADME Toxicology Testing Market is expected to grow at a CAGR of 11.3% by 2028
Market Analysis and Insights: Asia-Pacific ADME Toxicology Testing Market
Asia-Pacific ADME toxicology testing market is expected to gain substantial growth in the forecast period of 2021-2028. Data Bridge Market Research analyzes that the market is growing at a CAGR of 11.3% in the forecast period and is expected to reach USD 1,210.28 million by 2028. Increasing demand for toxicology testing products and rising investments in R&D by key market players are major drivers expected to propel the growth of the market in the forecast period.
ADME refers to the absorption, distribution, metabolism and elimination of drugs or chemicals in and from the body. ADME testing plays a vital role in the drug development process. The testing enables pharmaceutical companies to reduce their drug discovery time, cost, and test complications.
ADME is a critical piece in drug development studies, which helps determine the viability of a drug. Toxicology study is a crucial part of drug development used to characterize a drug's toxicity profile by identifying its impact on organ structure/ functionality. The study provides critical information and knowledge used by regulatory agencies to prevent or reduce the likelihood that a disease or other negative health outcome would occur. The food and Drug Administration has issued several guidance documents for industry such as safety testing of drug metabolites, In vitro metabolism and transporter-mediated drug-drug interaction studies, clinical drug interactions studies.
Get the sample copy of the report :
Asia-Pacific ADME Toxicology Testing Market Scope and Market Size
Asia-Pacific ADME toxicology testing market is segmented on the basis of technology, product type, test, method, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of technology, the Asia-Pacific ADME toxicology testing market is segmented into cell culture, high throughput, molecular imaging, and omics technology. The cell culture segment is expected to dominate the market in 2021 owing to increasing research and development activities along with technological advancements.
- On the basis of product type, the Asia-Pacific ADME toxicology testing market is segmented into instruments, assays & reagents, accessories and software solutions. In 2021, assays & reagents segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to increase in rate of late stage drug failure, and rise in need of novel drug molecules are predicted to dominate the market.
Competitive Landscape and ADME Toxicology Testing Market Share Analysis
The ADME toxicology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific ADME toxicology testing market.
The major companies which are dealing in the Asia-Pacific ADME toxicology testing market are Promega Corporation, Lonza, AAT Bioquest, Inc., Thermo Fisher Scientific Inc., Corning Incorporated, Charles River Laboratories, LABCYTE INC., BioIVT, Takara Bio Inc., Agilent Technologies, Inc., PromoCell GmbH, Merck KGaA, and Bio-Rad Laboratories, Inc., among others.
Browse Trending Reports:
https://www.gifyu.com/image/Sub11
https://www.imagevenue.com/ME16ETRB
https://cubeupload.com/im/Digikets78/75eAsiaPacificADMEToxic.jpg
https://imagizer.imageshack.com/img923/1197/o869Ns.jpg
https://www.turboimagehost.com/p/89322865/Asia-Pacific_ADME_Toxicology_Testing_Market.jpg.html
https://www.gifyu.com/image/Sub1A
https://www.imagevenue.com/ME16ETRC
https://photos.google.com/photo/AF1QipNmpoRZ_Q2qO0fPbLlVpG9R2xQ4djulYs-UanxB
https://cubeupload.com/im/Digikets78/GlobalADMEToxicology.jpg
https://imagizer.imageshack.com/img922/3706/pxSw8s.jpg
https://www.turboimagehost.com/p/89322866/Global_ADME_Toxicology_Testing_Market.jpg.html
https://www.gifyu.com/image/Sub1B
https://www.imagevenue.com/ME16ETRD
https://photos.google.com/photo/AF1QipOdV025LniYEYV5xl-czcn1j9My1sjGpl2npYOA
https://cubeupload.com/im/Digikets78/GlobalDiagnosticCath.jpg
https://imagizer.imageshack.com/img922/8067/xYeyZV.jpg
https://www.turboimagehost.com/p/89322868/Global_Diagnostic_Catheter_Market.jpg.html
https://www.gifyu.com/image/Sub1D
https://www.imagevenue.com/ME16ETRE
https://photos.google.com/photo/AF1QipMiPWxm55pcnTBvhih8pVD6Sor1tttCR1Nbva2K
https://cubeupload.com/im/Digikets78/GlobalPlacentalProte.jpg
https://imagizer.imageshack.com/img923/4058/XNLycp.jpg
https://www.turboimagehost.com/p/89322869/Global_Placental_Protein_Market.jpg.html
https://www.gifyu.com/image/Sub1o
https://www.imagevenue.com/ME16ETRF
https://photos.google.com/photo/AF1QipPdRKTuIQ1FofZdlyySGOSg7gAaszMUvEmsvYwM
https://cubeupload.com/im/Digikets78/6f7GlobalTransplantDiag.jpg
https://imagizer.imageshack.com/img924/4953/cQ6fAh.jpg
https://www.turboimagehost.com/p/89322870/Global_Transplant_Diagnostics_Market.jpg.html
https://www.gifyu.com/image/Sub1y
https://www.imagevenue.com/ME16ETRG
https://photos.google.com/photo/AF1QipO0FOS0FZ3idiIbBEINPhSsTBVXK4TrvOtx16yA
https://cubeupload.com/im/Digikets78/78NorthAmericaNeurosur.jpg
https://imagizer.imageshack.com/img924/4602/KZzZOC.jpg
https://www.turboimagehost.com/p/89322872/North_America_Neurosurgery_Market.jpg.html
https://www.gifyu.com/image/Sub1G
https://www.imagevenue.com/ME16ETRI
https://photos.google.com/photo/AF1QipOTUvFiGP1mBX4Ia0zp_KFvCaaaVzkZxMbVVYmw
https://cubeupload.com/im/Digikets78/c92USRemotePatientMonit.jpg
https://imagizer.imageshack.com/img922/6475/NvjZzU.jpg
https://www.turboimagehost.com/p/89322873/U.S_Remote_Patient_Monitoring_Market.jpg.html
Comments
Post a Comment